JP Morgan Chase’s Cardinal Health CAH Stock Holding History

JP Morgan Chase’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-100,000	Closed	-$15.7M	–	7460
2025 Q3	$15.7M	Buy	+100,000	New	+$15.4M	﹤0.01%	2302
2023 Q1	–	Sell	-13,300	Closed	-$1.02M	–	6722
2022 Q4	$1.02M	Buy	13,300 +4,400	+49%	+$334K	﹤0.01%	4021
2022 Q3	$593K	Hold	8,900	–	–	﹤0.01%	4347
2022 Q2	$465K	Hold	8,900	–	–	﹤0.01%	4610
2022 Q1	$505K	Sell	8,900 -7,500	-46%	-$402K	﹤0.01%	4686
2021 Q4	$844K	Hold	16,400	–	–	﹤0.01%	4507
2021 Q3	$811K	Buy	+16,400	New	+$890K	﹤0.01%	4454
2018 Q1	–	Sell	-25,900	Closed	-$1.59M	–	5394
2017 Q4	$1.59M	Hold	25,900	–	–	﹤0.01%	3449
2017 Q3	$1.74M	Buy	+25,900	New	+$1.83M	﹤0.01%	3240

Other funds holding CAH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase's CAH Position: Q1 2026 in Review

JP Morgan Chase reduced its Cardinal Health (CAH) stake by 12% in Q1 2026, selling an estimated $67.7M and leaving 2,316,644 shares worth $478M. The position accounts for 0.03% of the portfolio, ranked #419.

JP Morgan Chase first reported a position in CAH in Q2 2013 and has held it in 52 quarters since. The position peaked at $575M in Q1 2025. 1,425 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

JP Morgan Chase held 2,316,644 shares of Cardinal Health worth $478M as of Q1 2026.
JP Morgan Chase sold 314,159 Cardinal Health shares in Q1 2026, an estimated $67.7M.
Cardinal Health made up 0.03% of JP Morgan Chase's portfolio in Q1 2026, its #419 holding.
JP Morgan Chase first reported a position in Cardinal Health in Q2 2013 and has held it in 52 quarters since.
JP Morgan Chase's Cardinal Health position peaked at $575M in Q1 2025.
1,425 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.